Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

809 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
D-Dimer elevation and adverse outcomes.
Halaby R, Popma CJ, Cohen A, Chi G, Zacarkim MR, Romero G, Goldhaber SZ, Hull R, Hernandez A, Mentz R, Harrington R, Lip G, Peacock F, Welker J, Martin-Loeches I, Daaboul Y, Korjian S, Gibson CM. Halaby R, et al. Among authors: gibson cm. J Thromb Thrombolysis. 2015 Jan;39(1):55-9. doi: 10.1007/s11239-014-1101-6. J Thromb Thrombolysis. 2015. PMID: 25006010 Free PMC article. Review.
Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy.
Gibson CM, Jennings LK, Murphy SA, Lorenz DP, Giugliano RP, Harrington RA, Cholera S, Krishnan R, Califf RM, Braunwald E; INTEGRITI Study Group. Gibson CM, et al. Circulation. 2004 Aug 10;110(6):679-84. doi: 10.1161/01.CIR.0000137912.11655.F6. Epub 2004 Jul 19. Circulation. 2004. PMID: 15262838 Clinical Trial.
Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction.
Kirtane AJ, Bui A, Murphy SA, Karmpaliotis D, Kosmidou I, Boundy K, Rahman A, Pinto DS, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, Gibson CM; TIMI Study Group. Kirtane AJ, et al. Among authors: gibson cm. J Thromb Thrombolysis. 2004 Jun;17(3):177-84. doi: 10.1023/B:THRO.0000040486.10549.f6. J Thromb Thrombolysis. 2004. PMID: 15353915 Clinical Trial.
Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial.
Gibson CM, Zorkun C, Molhoek P, Zmudka K, Greenberg M, Mueller H, Wesdorp J, Louwerenburg H, Niederman A, Westenburg J, Bikkina M, Batty J, de Winter J, Murphy SA, McCabe CH. Gibson CM, et al. J Thromb Thrombolysis. 2006 Aug;22(1):13-21. doi: 10.1007/s11239-006-8080-1. J Thromb Thrombolysis. 2006. PMID: 16786228 Clinical Trial.
Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days.
Pride YB, Buros JL, Lord E, Southard MC, Harrigan CJ, Ciaglo LN, Sabatine MS, Cannon CP, Gibson CM; TIMI Study Group. Pride YB, et al. Among authors: gibson cm. J Thromb Thrombolysis. 2008 Oct;26(2):106-12. doi: 10.1007/s11239-007-0075-z. Epub 2007 Jul 12. J Thromb Thrombolysis. 2008. PMID: 17624497
Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction.
Appelbaum E, Kirtane AJ, Clark A, Pride YB, Gelfand EV, Harrigan CJ, Kissinger KV, Manning WJ, Gibson CM. Appelbaum E, et al. Among authors: gibson cm. J Thromb Thrombolysis. 2009 Feb;27(2):123-9. doi: 10.1007/s11239-008-0197-y. Epub 2008 Feb 2. J Thromb Thrombolysis. 2009. PMID: 18246410
809 results